About TherapySelector
The app for physicians to choose a personalized treatment for their patient within 1 minute TherapySelector supports you as a physician to easily and quickly choose a data-based, personalized treatment for hypertension...
The app for physicians to choose a personalized treatment for their patient within 1 minute
TherapySelector supports you as a physician to easily and quickly choose a data-based, personalized treatment for hypertension and hepatitis C for and with your patient during consultation hours.
The app shows in a single glance information about the effectiveness of medication based on the disease remission (systolic blood pressure lower than 140 mm Hg for hypertension and viral clearance in hepatitis C), the likelihood of adverse events, cost and patient group size. This overview allows you to easily and quickly decide on the best personalized treatment method for your patient, based on study data.
How does TherapySelector work?
First you enter the requested characteristics of your patient by answering 4 simple questions about etiology, disease stage, previous treatments and comorbidities. Based on this, a profile of the patient is determined. The app then shows an overview of all registered treatments for that specific patient profile, based on frequently updated study results. For each therapy you find information about effectiveness, possible adverse events and costs.
TherapySelector currently provides the following features:
• Determination of patient profiles based on four simple questions about the patient.
• Probability of "success" of all registered medication (combinations) for hypertension and hepatitis C, together with the probability of adverse events associated with the patient profile, based on individual patient data from key clinical scientific studies.
• For hypertension: overview of therapy options with Thiazide diuretics (THZ), Calcium Channel Blockers (CCA), ACE inhibitors (ACEi) or Angiotensin Receptor Blockers (ARB). Information on monotherapy with dose increase (Titrate), and results of stepwise addition of medication (Titrate & Add).
• Detail information, including information about dosage (of the therapy regime) and the cost of a specific treatment.
• Availability in both English and Dutch.
TherapySelector is intended to provide physicians and patients personalized information to support them in choosing the most appropriate treatment. In doing so, the app complements guidelines that are based on the ‘average’ patient. The TherapySelector app can be used without creating an account.
Developed with (academic) medical centers and research institutes
TherapySelector is being developed by TherapySelector in collaboration with physicians and scientists associated with universities and leading academic medical centers such as the Erasmus MC, LUMC and MUMC+. The data in the app has been authorized by specialists from Dutch scientific associations.
The results are calculated using anonymous patient data from scientific studies of published randomized controlled trials, other phase 2 & 3 studies and prospective real-life studies around the world (high quality research). Research groups and sponsors make their data available for this purpose.
About TherapySelector
TherapySelector B.V. is a social enterprise. Our mission is to improve health care globally by enriching it with personalized treatment information based on the most recent data from scientific studies. It is not our goal to make profit.
With the TherapySelector app, we facilitate doctors with personalized care to achieve health gains for their patients. Additionally, we want to aid in controlling the rising costs of healthcare for the public, e.g. by preventing over- and under-treatment.
Follow us on LinkedIn (https://www.linkedin.com/company/therapyselector) or visit www.therapyselector.com.
Apr 27, 2024
Version 4.1.0
New in this release:
• Change of the patient profile for Hypertension; African descent is no longer included as an option given the scientific discussion of race as a predictive factor
• Addition of data from over 50,000 patients from the ALLHAT and VALUE studies
Previous Versions
Here you can find the changelog of TherapySelector since it was posted on our website on 2016-11-04 23:28:26.
The latest version is 4.1.0 and it was updated on 2024-04-28 09:41:51. See below the changes in each version.
TherapySelector version 4.1.0
Updated At: 2024-04-27
Changes: Apr 27, 2024
Version 4.1.0
New in this release:
• Change of the patient profile for Hypertension; African descent is no longer included as an option given the scientific discussion of race as a predictive factor
• Addition of data from over 50,000 patients from the ALLHAT and VALUE studies
TherapySelector version 4.0.19
Updated At: 2024-01-25
Changes: Jan 25, 2024
Version 4.0.19
New in this release:
- Clearer explanation in results screen of hypertension: the text is enriched with visual elements
- Equivalence tables: directly accessible from the results screen and details screen to easily translate the study medication to your preferred medication
- Terms of use: we value transparency when using the app
Do you have comments or encounter problems? Use the new feature to rate the app.
TherapySelector version 4.0.18
Updated At: 2023-11-16
Changes: Nov 16, 2023
Version 4.0.18
After introducing Patient profile Suggestions for hepatitis C, in this release we are also launching Patient profile Suggestions for hypertension. If not enough data is available for your chosen patient profile, we now provide several suggestions. These suggestions are based on patient profiles where one patient characteristic has been removed from the profile.
We have also made some minor adjustments to the patient profile options for hypertension.
If you have any remarks or issues, please send us your feedback via the app.
TherapySelector version 4.0.17
Updated At: 2023-10-02
Changes: Oct 2, 2023
Version 4.0.17
In this release, we are launching some major changes.
• Suggestions for Hepatitis C: If there is not enough data available for your chosen patient profile, we now provide several suggestions. These suggestions are based on patient profiles where one patient characteristic has been removed from the profile.
• Pre-release Hypertension: we added the hypertension module as a pre-release in TherapySelector. You can already use this module in practice, although more data is needed for a full overview of therapy choices. We are currently processing data from more than 60,000 patients.
If you have any remarks or issues, please send us your feedback via the app.
TherapySelector version 4.0.16
Updated At: 2023-06-05
Changes: Jun 5, 2023
Version 4.0.16
In this release, we have made the following improvements:
• We made it easier for you to select a patient profile by introducing a dropdown.
• In the detail screen, you can collapse and expand the accordions all at once.
• The loading of the screens is now faster.
If you have any remarks or issues, please send us your feedback via the app.
TherapySelector version 2.1
Updated At: 2016-11-01
Disclaimer
Official App Store Link
We do not host TherapySelector on our servers. We did not scan it for viruses, adware, spyware or other type of malware. This app is hosted by Apple and passed their terms and conditions to be listed there. We recommend caution when installing it.
The App Store link for TherapySelector is provided to you by apps112.com without any warranties, representations or guarantees of any kind, so access it at your own risk.
If you have questions regarding this particular app contact the publisher directly. For questions about the functionalities of apps112.com contact us.
